Lv2
160 积分 2026-06-26 加入
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
1天前
待审核
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
1天前
待审核
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
1天前
待审核
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
1天前
待审核
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
1天前
待审核
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
1天前
已采纳
Oral bioaccessibility of metal(oid)s in commercial zeolite used as a dietary supplement: Implications to human health risk
1天前
已采纳
Bisabolane and drimane sesquiterpenes from the fungus Trametes versicolor
1天前
待审核
Ni/Ti3C2Tx catalysts for hydrogen production from ethanol via aqueous-phase reforming: Effects of surface-terminating species, residence time, and reaction temperature
1天前
待审核
Thermally insulating and ultralow-k fluorinated polyimide aerogels with multi-level porous structure
1天前
已采纳